Entering text into the input field will update the search result below

Celldex Therapeutics (CLDX) CEO Anthony Marucci on Q3 2017 Results - Earnings Call Transcript

Mar. 07, 2018 8:42 PM ETCelldex Therapeutics, Inc. (CLDX)13 Comments
SA Transcripts profile picture
SA Transcripts

Celldex Therapeutics, Inc. (NASDAQ:CLDX) Q3 2017 Earnings Conference Call March 8, 2018 4:30 PM ET


Anthony Marucci - Co-Founder, President, Chief Executive Officer

Dr. Tibor Keler - Co-Founder, Executive Vice President, Chief Scientific Officer

Sam Martin - Senior Vice President, Chief Financial Officer

Sarah Cavanaugh - Senior Vice President, Corporate Affairs and Administration


Mara Goldstein - Cantor Fitzgerald

Boris Peaker - Cowen

Joe Pantginis - HC Wainwright

Tony Butler - Guggenheim Securities


Good day ladies and gentlemen and welcome to the Celldex Therapeutics, Year End 2017 Conference Call. At this time all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions]. As a reminder, this conference is being recorded.

I would now like to introduce your host for today’s conference, Sarah Cavanaugh, you may begin.

Sarah Cavanaugh

Thank you. Good afternoon and thank you for joining us. Today on the call I have Anthony Marucci, Co-Founder, President and CEO of Celldex Therapeutics; Dr. Tibor Keler, Co-Founder, Executive Vice President and Chief Scientific Officer; and Sam Martin, Senior Vice President and Chief Financial Officer.

Before we begin our discussion, I'd like to mention that today's speakers will be making forward-looking statements. Such statements reflect our current views with respect to future events and are based on assumptions subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such forward-looking statements.

Certain of the factors that might cause Celldex's actual results to differ materially from those in the forward-looking statements include those set forth under the headings Risk Factors and management's discussion and analysis of financial condition and results of operations in Celldex's annual report on Form 10-K, quarterly report on Form 10-Q, and its current reports on Form

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.